NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

learningcurve2020,

QPs are not ordinary lab techs. They are highly trained and qualified. They are in limited supply. Under artisan methods 30 hours of QP time are needed per batch/patient for product release only. This is not a lab tech making the product but just the overseer of the product to release it once it is made. To treat 50 patients per month would require about 9 QPs Working 40 hour work weeks. Taking it up to 100 patients per month takes it to 18 QPs needed. That takes care of initial ramp up. Once you move beyond initial ramp you encounter severe limitations because of the limitations on available QP personnel. In the past, a number of positions remained open for a significant amount of time. Once ramp up gets past initial stages there will be no time available for positions to be filled while demand soars not only in GBM, rGBM and lower grade gliomas but in clinical trials and off label or tissue agnostic designated settings.
Trying to create a simplistic version of what is going on for investors to consume to generate angst amongst them because of the slowness of “the process” won’t work with long time longs; ). Best wishes.